An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape ...

In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined ...

Scientists have developed AMT-130, a gene therapy that significantly slows Huntington's disease progression, marking a ...

This One Breakthrough Could Obliterate Disease — But What’s the Catch for Patients?”, “content”: “ Imagine a medical treatment that doesn’t just manage symptoms, but actually corrects the very ...

Dr. Shy's decades of work have helped identify CMT genes and establish research networks, while he has cared for ...

Enloe Health announced Monday that was selected to receive a $9 million grant from the California Institute for Regenerative ...

A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with ...

Editas Medicine (EDIT) downgraded to Hold as it pivots to in vivo CRISPR EDIT-401; timeline and cash runway into 2H 2028.

Prime Medicine PRME shares have gained approximately 26% over the past month against the industry’s 2.8% decline, supported ...

A Hong Kong model compared upfront NGS with EGFR/ALK-first testing in metastatic NSCLC, highlighting trade-offs in cost, ...

IISc Bengaluru has opened applications for its online genetic engineering course. Check eligibility, Rs 11,800 fee, course dates and the November 10 deadline.

Boost ROI via partnerships, acquisitions, AI-enabled high-throughput screening, broader product portfolios, and local production to cut costs and accelerate commercialization.Dublin, Oct. 12, 2026 ...